• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合蛋白质组学和转录组学研究表明,IL-6R/JAK2/STAT3/MMP9信号通路的激活与垂体无功能腺瘤的侵袭相关。

Integrative proteomics and transcriptomics revealed that activation of the IL-6R/JAK2/STAT3/MMP9 signaling pathway is correlated with invasion of pituitary null cell adenomas.

作者信息

Feng Jie, Yu Sheng-Yuan, Li Chu-Zhong, Li Zhen-Ye, Zhang Ya-Zhuo

机构信息

Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Beijing Institute for Brain Disorders Brain Tumor Center, China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, 100050, China.

Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Beijing Institute for Brain Disorders Brain Tumor Center, China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, 100050, China; Department of Neurosurgery, Shandong Provincial Hospital, Shandong University, Jinan, 250021, China.

出版信息

Mol Cell Endocrinol. 2016 Nov 15;436:195-203. doi: 10.1016/j.mce.2016.07.025. Epub 2016 Jul 25.

DOI:10.1016/j.mce.2016.07.025
PMID:27465831
Abstract

Non-functioning pituitary adenomas (NFPAs) are a highly heterogeneous group, but few studies have explored the invasion mechanism of specific subtypes of NFPAs. The objective of this study was to investigate the differential molecular expression patterns and the critical biological signaling pathways involved in the invasion of pituitary null cell adenomas (PNCAs) through integrative proteomics and transcriptomics. A total of 1160 genes and 283 proteins were found to be differentially expressed in invasive and non-invasive PNCAs. The differentially expressed molecules related to invasion were enriched in 15 canonical signaling pathways, 15 clusters of diseases or biological functions and 5 upstream molecules. Among them, the majority of the differentially expressed molecules were found to be involved in transport of molecule, migration of cells and cell movement. Notably, IL-6 was a significantly activated upstream regulator, and the IL6R/JAK2/STAT3 cascade was found to play a critical role in acute phase response signaling, which was the most significant canonical signaling pathway. Furthermore, we validated the overexpression of IL-6R, JAK2, STAT3, p-STAT3 and MMP9 in invasive PNCAs. Our data suggest that overactivation of the IL-6R/JAK2/STAT3/MMP9 pathway is critical for the invasion of PNCAs.

摘要

无功能垂体腺瘤(NFPAs)是一个高度异质性的群体,但很少有研究探讨NFPAs特定亚型的侵袭机制。本研究的目的是通过整合蛋白质组学和转录组学,研究垂体无细胞腺瘤(PNCAs)侵袭过程中差异分子表达模式及关键生物学信号通路。共发现1160个基因和283种蛋白质在侵袭性和非侵袭性PNCAs中差异表达。与侵袭相关的差异表达分子富集于15条经典信号通路、15个疾病或生物学功能簇以及5个上游分子中。其中,大多数差异表达分子参与分子转运、细胞迁移和细胞运动。值得注意的是,IL-6是一个显著激活的上游调节因子,且发现IL6R/JAK2/STAT3级联在急性期反应信号通路中起关键作用,这是最显著的经典信号通路。此外,我们验证了IL-6R、JAK2、STAT3、p-STAT3和MMP9在侵袭性PNCAs中的过表达。我们的数据表明,IL-6R/JAK2/STAT3/MMP9通路的过度激活对PNCAs的侵袭至关重要。

相似文献

1
Integrative proteomics and transcriptomics revealed that activation of the IL-6R/JAK2/STAT3/MMP9 signaling pathway is correlated with invasion of pituitary null cell adenomas.整合蛋白质组学和转录组学研究表明,IL-6R/JAK2/STAT3/MMP9信号通路的激活与垂体无功能腺瘤的侵袭相关。
Mol Cell Endocrinol. 2016 Nov 15;436:195-203. doi: 10.1016/j.mce.2016.07.025. Epub 2016 Jul 25.
2
Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.整合蛋白质组学和转录组学鉴定无功能垂体腺瘤新的侵袭相关生物标志物。
Tumour Biol. 2016 Jul;37(7):8923-30. doi: 10.1007/s13277-015-4767-2. Epub 2016 Jan 11.
3
Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.在人类垂体无功能细胞腺瘤和嗜酸细胞瘤中鉴定与侵袭性相关的亚型特异性ENC1基因。
J Neurooncol. 2014 Sep;119(2):307-15. doi: 10.1007/s11060-014-1479-1. Epub 2014 Jun 11.
4
ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.ADAM12 通过 EGFR/ERK 信号通路诱导垂体腺瘤中的 EMT 并促进细胞迁移、侵袭和增殖。
Biomed Pharmacother. 2018 Jan;97:1066-1077. doi: 10.1016/j.biopha.2017.11.034. Epub 2017 Nov 9.
5
A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.一种在三种无功能垂体腺瘤亚型中的新型侵袭相关生物标志物。
World Neurosurg. 2017 Apr;100:514-521. doi: 10.1016/j.wneu.2017.01.010. Epub 2017 Jan 16.
6
Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.恶性腹水在体外增强了具有膜结合白细胞介素-6受体的卵巢癌细胞的迁移和侵袭特性。
Oncotarget. 2016 Dec 13;7(50):83148-83159. doi: 10.18632/oncotarget.13074.
7
TNF-α can promote membrane invasion by activating the MAPK/MMP9 signaling pathway through autocrine in bone-invasive pituitary adenoma.TNF-α 可通过自分泌激活 MAPK/MMP9 信号通路促进侵袭性骨垂体腺瘤的膜侵袭。
CNS Neurosci Ther. 2024 May;30(5):e14749. doi: 10.1111/cns.14749.
8
Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.侵袭性无功能垂体腺瘤中 sFRP 和 WIF1 基因的异常表达。
Mol Cell Endocrinol. 2018 Oct 15;474:168-175. doi: 10.1016/j.mce.2018.03.005. Epub 2018 Mar 16.
9
Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.通过分析微小RNA表达谱鉴定无功能侵袭性垂体腺瘤的新型生物标志物。
Biochem Genet. 2017 Jun;55(3):253-267. doi: 10.1007/s10528-017-9794-9. Epub 2017 Mar 17.
10
miR-34b Alleviates High Glucose-Induced Inflammation and Apoptosis in Human HK-2 Cells via IL-6R/JAK2/STAT3 Signaling Pathway.miR-34b 通过 IL-6R/JAK2/STAT3 信号通路减轻高糖诱导的人 HK-2 细胞炎症和凋亡。
Med Sci Monit. 2019 Oct 30;25:8142-8151. doi: 10.12659/MSM.917128.

引用本文的文献

1
A Nexus of Biomolecular Complexities in Pituitary Neuroendocrine Tumors: Insights into Key Molecular Drivers.垂体神经内分泌肿瘤中生物分子复杂性的关联:对关键分子驱动因素的见解
Biomedicines. 2025 Apr 16;13(4):968. doi: 10.3390/biomedicines13040968.
2
New insights in cellular senescence: The pituitary model.细胞衰老的新见解:垂体模型。
J Neuroendocrinol. 2025 May;37(5):e70008. doi: 10.1111/jne.70008. Epub 2025 Mar 3.
3
Transcriptome-Wide Analysis of Pituitary and Ectopic Adrenocorticotropic Hormone-Secreting Tumors.垂体及异位促肾上腺皮质激素分泌肿瘤的全转录组分析
Cancers (Basel). 2025 Feb 15;17(4):658. doi: 10.3390/cancers17040658.
4
Research status and prospects of pituitary adenomas in conjunction with neurological and psychiatric disorders and the tumor microenvironment.垂体腺瘤合并神经和精神疾病及肿瘤微环境的研究现状与展望
Front Neurosci. 2024 Apr 22;18:1294417. doi: 10.3389/fnins.2024.1294417. eCollection 2024.
5
Transcriptome Analysis Reveals Distinct Patterns Between the Invasive and Noninvasive Pituitary Neuroendocrine Tumors.转录组分析揭示侵袭性和非侵袭性垂体神经内分泌肿瘤之间的不同模式。
J Endocr Soc. 2024 Mar 1;8(5):bvae040. doi: 10.1210/jendso/bvae040. eCollection 2024 Mar 12.
6
STAT3 Deficiency Alters the Macrophage Activation Pattern and Enhances Matrix Metalloproteinase 9 Expression during Staphylococcal Pneumonia.STAT3 缺失改变了金黄色葡萄球菌性肺炎期间的巨噬细胞激活模式并增强了基质金属蛋白酶 9 的表达。
J Immunol. 2024 Jan 1;212(1):69-80. doi: 10.4049/jimmunol.2300151.
7
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.非功能性垂体神经内分泌肿瘤的诊断和治疗的最新证据更新。
Endocrinol Metab (Seoul). 2023 Dec;38(6):631-654. doi: 10.3803/EnM.2023.1838. Epub 2023 Nov 15.
8
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways.侵袭性 PitNETs 及潜在的靶向治疗:分子和遗传途径的系统综述。
Int J Mol Sci. 2023 Oct 29;24(21):15719. doi: 10.3390/ijms242115719.
9
Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.验证 Myc 相关蛋白 X (MAX) 在生长激素分泌型和无功能型垂体腺瘤中的调控作用。
PLoS One. 2023 Apr 27;18(4):e0284949. doi: 10.1371/journal.pone.0284949. eCollection 2023.
10
Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics.通过蛋白质组学抑制 PP2A 上调 B7-H3 的表达,并可能增加恶性脑膜瘤对免疫治疗的敏感性。
Pathol Oncol Res. 2022 Sep 20;28:1610572. doi: 10.3389/pore.2022.1610572. eCollection 2022.